KRAS and non-small cell lung carcinoma: A range of alterations is observed in non-G12C KRAS-mutant NSCLC; these variations include other point mutations at codon 12 of exon 2 such as KRAS G12V and G12D, which account for approximately 21% and 17% of KRAS mutations, respectively [11].